We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
DuPont and Bock Ink Deal to Expand in Biogas Enzymes Market
Read MoreHide Full Article
DuPont’s (DD - Free Report) Industrial Biosciences unit and Bock UK Ltd recently entered into a strategic partnership deal. Under the collaboration, DuPont plans to provide its enzyme biotechnology – Optimash AD-100 – to Bock for distribution of biogas enzymes for U.K. customers.
The technology will help biogas producers in the agricultural sector to strengthen process and improve product yield. Optimash AD-100 is an easy to use and innovative liquid enzyme that has shown to increase biogas yields in anaerobic digesters by up to 13%. This technology accelerates the breakdown of various materials including grasses, maize silage, straw, and some food wastes, which results in more suitable conversion of sugar into biogas. It will also help customers to improve revenues and profitability as well as increase offerings in the renewable energy space.
DuPont entered the growing biogas space with the launch of its Optimash AD-100 in Jul 2016. The company announced that the strategic partnership with Bock will improve biogas production and economics for the customers in the U.K. through the use of its enzyme technologies.
The collaboration will leverage DuPont’s reputation as a global leader in the industrial biotechnology space and Bock’s capabilities in silage storage across the U.K. anaerobic digestion (AD) industry to offer exceptional products to customers that will eventually increase the financial performance of U.K. AD plants.
DuPont has outperformed the Zacks categorized Chemicals-Diversified industry in the last six months. The company’s shares have rallied 10.1% during this period compared with the industry’s gain of around 9.7%.
DuPont is well placed to gain from its cost-cutting measures and new product launches. It has numerous products in its pipeline that are expected to contribute to the top-line growth.
Moreover, the proposed mega-merger with Dow Chemical (DOW - Free Report) is expected to deliver cost synergies of around $3 billion and growth synergies of roughly $1 billion. The companies expect the closing of the merger to take place in Aug 2017.
E.I. du Pont de Nemours and Company Price and Consensus
Sherwin-Williams has an expected long-term earnings growth rate of 11.4%.
Quaker Chemical has an expected long-term earnings growth rate of 8.5%.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
DuPont and Bock Ink Deal to Expand in Biogas Enzymes Market
DuPont’s (DD - Free Report) Industrial Biosciences unit and Bock UK Ltd recently entered into a strategic partnership deal. Under the collaboration, DuPont plans to provide its enzyme biotechnology – Optimash AD-100 – to Bock for distribution of biogas enzymes for U.K. customers.
The technology will help biogas producers in the agricultural sector to strengthen process and improve product yield. Optimash AD-100 is an easy to use and innovative liquid enzyme that has shown to increase biogas yields in anaerobic digesters by up to 13%. This technology accelerates the breakdown of various materials including grasses, maize silage, straw, and some food wastes, which results in more suitable conversion of sugar into biogas. It will also help customers to improve revenues and profitability as well as increase offerings in the renewable energy space.
DuPont entered the growing biogas space with the launch of its Optimash AD-100 in Jul 2016. The company announced that the strategic partnership with Bock will improve biogas production and economics for the customers in the U.K. through the use of its enzyme technologies.
The collaboration will leverage DuPont’s reputation as a global leader in the industrial biotechnology space and Bock’s capabilities in silage storage across the U.K. anaerobic digestion (AD) industry to offer exceptional products to customers that will eventually increase the financial performance of U.K. AD plants.
DuPont has outperformed the Zacks categorized Chemicals-Diversified industry in the last six months. The company’s shares have rallied 10.1% during this period compared with the industry’s gain of around 9.7%.
DuPont is well placed to gain from its cost-cutting measures and new product launches. It has numerous products in its pipeline that are expected to contribute to the top-line growth.
Moreover, the proposed mega-merger with Dow Chemical (DOW - Free Report) is expected to deliver cost synergies of around $3 billion and growth synergies of roughly $1 billion. The companies expect the closing of the merger to take place in Aug 2017.
E.I. du Pont de Nemours and Company Price and Consensus
E.I. du Pont de Nemours and Company Price and Consensus | E.I. du Pont de Nemours and Company Quote
DuPont currently carries a Zacks Rank #2 (Buy).
Other Stocks to Consider
Some other top-ranked companies in the basic materials space include The Sherwin-Williams Company (SHW - Free Report) and Quaker Chemical Corporation (KWR - Free Report) . Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks Rank #1 stocks here.
Sherwin-Williams has an expected long-term earnings growth rate of 11.4%.
Quaker Chemical has an expected long-term earnings growth rate of 8.5%.
Today's Stocks from Zacks' Hottest Strategies
It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.
And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation. See Them Free>>